- Global Pharma News & Resources

Variscite Subverts Component Crises with Launch of Additional Production Line

New internal line improves output by 25 percent to help maintain rapid delivery times

TEL AVIV, Israel--(BUSINESS WIRE)--Variscite, a leading System-on-Module designer and manufacturer, launched a new production line which increased in-house manufacturing capabilities at its production and warehouse facilities by 25 percent to help bypass the component crisis due to the impact of COVID and supply chain challenges. The company last placed a new line into production a year ago, making this the second production increase during the pandemic. The new internal production line is now online and ensures delivery times as fast as four working days.

Variscite experts have developed end-to-end solutions that deliver core technology capabilities across a unique range of industries, including medical, agriculture, automotive, control systems and multimedia. The company’s in-house production facilities are equipped with the most-advanced Surface Mount Technology (SMT) machines, ensuring high-quality Modules and a wide range of configuration choices for every SoM. In having established its own internal production lines, Variscite retains better control of lead times during both normal operations and during challenging time periods, such as the current worldwide component supply crisis.

Included among the measures Variscite adopted to ensure stable and short deliveries to its clients are:

  • Placing orders of supplies early and building buffers to compensate for interruptions
  • Finding alternative sources of components that have low availability
  • Producing at least partial quantities of components as soon as it has materials so that stock will be ready for orders when needed
  • Leveraging platinum-level relationships with NXP and other long-term partners to ensure priority supply replenishments

“Thanks to Variscite’s rapid business decisions and full control over production, we were able to maintain full operations during the entirety of the COVID crisis,” said Ofer Austerlitz, VP Business Development and Sales of Variscite. “It required us to be agile and establish a safe environment for our employees, but we didn’t stop manufacturing at any point. The decision to bring an additional internal line into production was part of the measures we adopted late in 2020 to ensure that manufacturing remains uninterrupted, allowing us to increase output while others face setbacks and delays.”

All Variscite production is performed at fully ISO 13485, 9001 and 14001 compliant facilities, satisfying international customer and regulatory requirements for a broad range of industries, including medical devices and related services. Fully integrated systems provide the critical components required to optimize product design, development and manufacturing. Additional information about how Variscite’s in-house capabilities are bypassing the current component crisis is available at


Variscite is a worldwide leading System on Module provider, setting the bar for embedded solutions since 2003 with high-quality modules. The company provides the broadest ARM-based SoM portfolio in the embedded market with a wide range of configuration options that cover an entire embedded product and application range; from entry-level to high-performance solutions. Variscite's in-house production fully complies with the strict medical ISO13485 and ISO9001 standards. Along with the company's ongoing online documentation and personal support as well as the generous longevity, the company's customers are enjoying consistent, reliable products and services starting from the earliest development stages throughout the end product life-cycle.


+972 (9) 9562910

Joe Austin

Editor Details

  • Company:
    • Businesswire
Last Updated: 08-Mar-2022